Pfizer is shifting its focus from COVID-related products to cancer drugs. Pfizer is shifting its focus on cancer drugs as the pharmaceutical giant tries to recover from a challenging period due to the decline of its COVID-19 business.

The $100 billion free trade agreement will boost exports, investments, and job creation while removing most import tariffs on industrial products from the bloc.

US lawmakers are now scrutinizing the claims that SpaceX's Starlink service is being used in Russia.

A Google Cloud engineer has publicly protested the company's work for Israel's military, which resulted in his termination.

Elon Musk's X is gearing up to enter the video streaming arena with the launch of a television app designed for Amazon and Samsung smart TVs.

Epic Games CEO Tim Sweeney said it was Apple's way of retaliating against antitrust lobbying, prompting an EU investigation and a possible billion-dollar fine for Apple.

With women comprising only 30% of the workforce, artificial intelligence fuels gender bias, notably in healthcare, where flawed algorithms can misdiagnose women.

China's Big Fund raises $27 billion to counter US tech restrictions, aiming for chip self-sufficiency amidst escalating tensions. US tightens curbs as China pushes for autonomy.

The successful weight loss trial of the amycretin pill pushed Novo Nordisk past Tesla in market value to $604 billion, increasing investor interest in innovative solutions for major health issues like obesity.

Oil prices remained relatively stable on Thursday, with Brent crude futures settling unchanged at $82.96 per barrel.